Boston Trust Walden Corp Purchases 13,791 Shares of CME Group Inc. $CME

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Boston Trust Walden increased its CME Group stake by 79.5% in the third quarter, buying 13,791 shares and ending the period with 31,142 shares valued at about $8.16 million.
  • CME Group beat quarterly earnings and revenue expectations, reporting EPS of $3.02 and revenue of $1.74 billion; revenue rose 10.6% year over year.
  • The company declared a quarterly dividend of $1.30 per share, equivalent to $5.20 annually and a 1.7% yield. Analysts’ consensus rating was “Hold,” with an average price target of $314.44.
  • Interested in CME Group? Here are five stocks we like better.

Boston Trust Walden Corp grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 79.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,142 shares of the financial services provider's stock after purchasing an additional 13,791 shares during the quarter. Boston Trust Walden Corp's holdings in CME Group were worth $8,159,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Bridgewater Advisors Inc. acquired a new stake in shares of CME Group in the 2nd quarter valued at about $612,000. Focus Financial Network Inc. bought a new stake in CME Group in the 3rd quarter valued at about $1,513,000. The Manufacturers Life Insurance Company acquired a new position in CME Group during the 2nd quarter worth approximately $53,671,000. Haverford Trust Co acquired a new position in CME Group during the 2nd quarter worth approximately $13,818,000. Finally, Bowie Capital Management LLC acquired a new position in CME Group during the 2nd quarter worth approximately $22,991,000. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In related news, insider Julie Winkler sold 10,079 shares of the stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the transaction, the insider owned 21,482 shares of the company's stock, valued at approximately $6,555,232.30. This trade represents a 31.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction on Thursday, October 22nd. The stock was sold at an average price of $302.50, for a total transaction of $121,000.00. Following the completion of the transaction, the director owned 25,244 shares in the company, valued at approximately $7,636,310. The trade was a 1.56% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 32,979 shares of company stock worth $9,552,762. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Down 0.3%

CME opened at $307.24 on Friday. The stock has a market cap of $109.97 billion, a PE ratio of 25.39, a P/E/G ratio of 3.76 and a beta of 0.15. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The business's fifty day simple moving average is $282.60 and its 200 day simple moving average is $280.66.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating analysts' consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. CME Group's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period last year, the firm posted $2.68 EPS. As a group, research analysts expect that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group's payout ratio is presently 42.66%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. JPMorgan Chase & Co. raised shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 price target on the stock in a research report on Thursday, October 22nd. Weiss Ratings upgraded shares of CME Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Friday, October 23rd. Barclays lifted their price objective on CME Group from $281.00 to $321.00 and gave the stock an "equal weight" rating in a report on Thursday, October 22nd. Piper Sandler restated an "overweight" rating and set a $330.00 target price (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. Finally, TD Cowen upped their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a "buy" rating in a report on Monday, October 5th. Ten analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of "Hold" and a consensus price target of $314.44.

Get Our Latest Stock Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group's exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines